Regeneron Pharmaceuticals, Inc.
REGN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000872589
In the last 90 days, Regeneron Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 5 sales; 1,342 institutions reported holding it in 13F filings for Q2 2026, worth $57.1B in total; Southeastern Asset Management (Longleaf) is the only superinvestor holding it.
13F holders, Q3 2021
Institutional positions in Regeneron Pharmaceuticals, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 1,022
- +60 vs. Q2 2021
- Shares held
- 90.4M
- +1.98M (+2.2%) vs. Q2 2021
- Total value
- $54.5B
- +$5.16B (+10.5%) vs. Q2 2021
- New holders
- 134
- 410 more added
- Sold out
- 74
- 326 more reduced
13 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting REGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1,342 | $57.1B |
| Q1 2026 | 1,401 | $69.8B |
| Q4 2025 | 1,387 | $70.7B |
| Q3 2025 | 1,243 | $49.0B |
| Q2 2025 | 1,201 | $46.9B |
| Q1 2025 | 1,290 | $59.0B |
| Q4 2024 | 1,320 | $66.6B |
| Q3 2024 | 1,393 | $97.5B |
| Q2 2024 | 1,335 | $98.9B |
| Q1 2024 | 1,313 | $89.3B |
| Q4 2023 | 1,274 | $80.3B |
| Q3 2023 | 1,180 | $75.1B |
| Q2 2023 | 1,168 | $66.2B |
| Q1 2023 | 1,196 | $76.1B |
| Q4 2022 | 1,161 | $66.9B |
| Q3 2022 | 1,081 | $64.0B |
| Q2 2022 | 1,066 | $55.0B |
| Q1 2022 | 1,097 | $64.5B |
| Q4 2021 | 1,081 | $56.9B |
| Q3 2021 | 1,022 | $54.5B |
| Q2 2021 | 975 | $49.6B |
| Q1 2021 | 926 | $42.3B |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Regeneron Pharmaceuticals, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Windmill Hill Asset Management Ltd | – | – | – | – | Not filed |
| Legacy Wealth Partners, Inc. | – | – | – | – | Not filed |
| Quantitative Value Technologies, LLC | – | – | – | – | Not filed |
| GoalVest Advisory LLC | – | – | – | – | Not filed |
| PNC Managed Account Solutions, Inc. | – | – | – | – | Not filed |
| First Horizon Corp | – | – | – | – | Not filed |
| Castleview Partners, LLC | – | – | – | – | Not filed |
| San Francisco Sentry Investment Group (Ca) | – | – | – | – | Not filed |
| FormulaFolio Investments, LLC | – | – | – | – | Not filed |